SRC Inhibition as a Potential Target for Parkinson's Disease Psychosis
A Randomised, Balanced, Double-blind Two-way Crossover Design Study to Evaluate the Effects of SRC Kinase Inhibitor, Saracatinib, on Brain Activity Associated With Visual Processing in Patients With Parkinson's Disease Psychosis. A Randomised, Balanced, Double-blind Two-way Crossover Design Study to Evaluate the Effects of SRC K ...